Juniorgruppe 'Klinische Epidemiologie und Systemmedizin'

Dr. Jürgen Prochaska

Leiter der Juniorgruppe

Die Juniorgruppe „Thrombotische Erkrankungen und antithrombotische Therapie“ ist als BMBF-geförderte Forschergruppe in der Klinischen Epidemiologie des CTH angesiedelt und befasst sich mit klinisch-relevanten Fragestellungen auf dem Gebiet der arteriellen und venösen Thrombose. Hierfür werden Biodatenbanken von Populationsstudien und Patientenkohorten in einem holistischen Ansatz – vom genetischen Hintergrund bis zum klinischen Outcome – für innovative wissenschaftliche Projekte genutzt.

Das wissenschaftliche Arbeitsprogramm untersucht Risikofaktoren für die Entstehung thrombotischer Erkrankungen im arteriellen und venösen Gefäßsystem und deren Folgeerkrankungen, insbesondere der Herzinsuffizienz. Ein besonderer Fokus liegt auf der Untersuchung von subklinischen Phänotypen kardiovaskulärer Erkrankungen, welche als frühe asymptomatische Pathologien von besonderem Interesse und Relevanz für präventivmedizinische Ansätze sind. Begleitet werden diese Forschungsvorhaben durch wissenschaftliche Projekte zur Diagnostik, Therapie und Prävention von thrombotischen Erkrankungen.

Forschungsschwerpunkte

• Diagnostik, Therapie und Prävention von thrombotischen Erkrankungen und deren Folgeerkrankungen
• Interaktion zwischen Hämostase und dem Auftreten und Fortschreiten von Herzinsuffizienz
• Zusammenhang zwischen Erkrankungen des venösen Gefäßsystems und der arteriellen kardiovaskulären Erkrankung

Kooperationspartner

Einrichtungen der Universitätsmedizin 

• PD Dr. Christian Becker, CTH
• Prof. Dr. Espinola-Klein, Zentrum für Kardiologie – Abt. für Angiologie
• Prof. Dr. Stavros Konstantinides und PD Dr. Mareike Lankeit, Klinische Studien, CTH
• Prof. Dr. Karl Lackner, Institut für Klinische Chemie und Laboratoriumsmedizin
• Prof. Dr. Thomas Münzel, Zentrum für Kardiologie
• Dr. Marina Panova-Noeva, Juniorgruppe Klinische Plättchen-Epidemiologie, CTH
• Prof. Dr. Philipp Wild, Klinische Epidemiologie, CTH
• Prof. Dr. Stefan Tenzer, Institut für Immunologie
• Prof. Dr. Miguel Andrade, JGU, Computational Biology and Data Mining
• Prof. Dr. Dr. Perikles Simon, JGU, Sprotmedizin
• Prof. Dr. Julia Weinmann-Menke (I. Med. Klinik)
• Prof. Dr. Andreas Daiber (Molekulare Kardiologie)

Nationale Partner

• Prof. Dr. S. Bode-Böger, Universitätsklinikum Magdeburg
• Prof. Dr. Abdelhak Zoubir, TU Darmstadt
• Prof. Dr. Armin Grau, Klinikum Ludwigshafen

Internationale Partner

• Prof. Dr. Hugo ten Cate und Dr. Henri Spronk, CARIM Maastricht, Niederlande
• Prof. Dr. Carolyn S. Lam, National Heart Center Singapore
• Prof. Dr. Sanjiv S. Shah, Chicago, USA

Drittmittelförderung

• Bundesministerium für Bildung und Forschung (CTH, 01EO1503)
• Bayer AG
• Novartis Pharma
• Boehringer Ingelheim

Team - Juniorgruppe Klinische Epidemiologie

Vincent ten Cate, M.Sc. – PostDoc

Dr. Felix Müller - PostDoc

Dr. Marc Wiliam Heidorn - PostDoc

cand. med. Judith Plöger – Medizinische Doktorandin

cand. med. Jannis Franz - Medizinischer Doktorand

cand. med. Matthias Grosch - Medizinischer Doktorand

cand. med. Sophie Moll - Medizinische Doktorandin

cand. rer. nat. Silav Neid - Naturwissenschaftliche Doktorandin

cand. rer. nat. Rieke Baumkötter - Naturwissenschaftliche Doktorandin

 

Datenmanagement (Klinische Epidemiologie) 

Andreas Schmitt (Prospectus), Stefanie Kurz (MyoVasc)

Heidrun Lamparter (thrombEVAL/VTEval), Bianca Zäpf (FOCUS Bioseq)

Dr. Dagmar Laubert-Reh (Gutenberg-Gesundheitsstudie)

Statistik (Klinische Epidemiologie)

Markus Nagler (thrombEVAL, VTEval, FOCUS Bioseq, Prospectus)

Andreas Schulz (GHS, MyoVasc)

 

Wissenschaftsmanagement (Klinische Epidemiologie)

Dr. Jaqueline Kandsberger

Reviews

• Panova-Noeva M, Eggebrecht L, Prochaska JH, Wild PS. Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease. Hamostaseologie 2019.
• Prochaska JH, Wild PS. Traffic-associated air pollution as a risk factor for cancer in individuals with coronary artery disease. Eur J Prev Cardiol. 2018.
• Prochaska JH, Arnold N, Jünger C, Münzel T, Wild PS. [Prevention of cardiovascular diseases]. Herz 2018.

Origialarbeiten

• Tröbs SO, Prochaska JH, Schwuchow-Thonke S, Schulz A, Müller F, Heidorn MW,
  Göbel S, Diestelmeier S, Lerma Monteverde J, Lackner KJ, Gori T, Münzel T, Wild
  PS. Association of Global Longitudinal Strain With Clinical Status and Mortality
  in Patients With Chronic Heart Failure. JAMA Cardiol. 2021.
• Ten Cate V, Prochaska JH, Schulz A, Koeck T, Pallares Robles A, Lenz M,
  Eggebrecht L, Rapp S, Panova-Noeva M, Ghofrani HA, Meyer FJ, Espinola-Klein C,
  Lackner KJ, Michal M, Schuster AK, Strauch K, Zink AM, Laux V, Heitmeier S,
  Konstantinides SV, Münzel T, Andrade-Navarro MA, Leineweber K, Wild PS. Protein
  expression profiling suggests relevance of non-canonical pathways in isolated
  pulmonary embolism. Blood. 2021.
• Arnold N, Merzenich H, Wingerter A, Schulz A, Schneider A, Prochaska JH,
  Göbel S, Neu MA, Henninger N, Panova-Noeva M, Eckerle S, Spix C, Schmidtmann I,
  Lackner KJ, Beutel ME, Pfeiffer N, Münzel T, Faber J, Wild PS. Promotion of
  Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-
  Term Survivors. J Am Heart Assoc. 2021.
• Eggebrecht L, Ludolph P, Göbel S, Panova-Noeva M, Arnold N, Nagler M, Bickel
  C, Lauterbach M, Hardt R, Cate HT, Lackner KJ, Espinola-Klein C, Münzel T,
  Prochaska JH, Wild PS. Cost saving analysis of specialized, eHealth-based
  management of patients receiving oral anticoagulation therapy: Results from the
  thrombEVAL study. Sci Rep. 2021.
• Reagh JJ, Zheng H, Stolz U, Parry BA, Chang AM, House SL, Giordano NJ, Cohen
  J, Singer AJ, Francis S, Prochaska JH, Zeserson E, Wild PS, Limkakeng AT Jr,
  Walters EL, LoVecchio F, Theodoro D, Hollander JE, Kabrhel C, Fermann GJ. Sex-
  related Differences in D-dimer Levels for Venous Thromboembolism Screening. Acad
  Emerg Med. 2021.
• Lenz M, Schulz A, Koeck T, Rapp S, Nagler M, Sauer M, Eggebrecht L, Ten Cate
  V, Panova-Noeva M, Prochaska JH, Lackner KJ, Münzel T, Leineweber K, Wild PS,
  Andrade-Navarro MA. Missing value imputation in proximity extension assay-based
  targeted proteomics data. PLoS One. 2020.
• Panova-Noeva M, Wagner B, Nagler M, Koeck T, Ten Cate V, Prochaska JH,
  Heitmeier S, Meyer I, Gerdes C, Laux V, Konstantinides S, Spronk HM, Münzel T,
  Lackner KJ, Leineweber K, Ten Cate H, Wild PS. Comprehensive platelet
  phenotyping supports the role of platelets in the pathogenesis of acute venous
  thromboembolism - results from clinical observation studies. EBioMedicine. 2020.
• Lagrange J, Wagner B, Nagler M, Ten Cate V, Pallares Robles A, Koeck T, Rapp
  S, Prochaska JH, Spronk HM, Wenzel P, Ruf W, Ten Cate H, Wild PS, Panova-Noeva
  M. Characterization of Thrombin Generation Curve Shape in Presence of Platelets
  from Acute Venous Thromboembolism Patients. J Clin Med. 2020.
• van Paridon PCS, Panova-Noeva M, van Oerle R, Schulz A, Prochaska JH, Arnold
  N, Schmidtmann I, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Hackeng TM, Ten
  Cate H, Wild PS, Spronk HMH. Relation between Tissue Factor Pathway Inhibitor
  Activity and Cardiovascular Risk Factors and Diseases in a Large Population
  Sample. Thromb Haemost. 2021.
• van Paridon PCS, Panova-Noeva M, van Oerle R, Schultz A, Hermanns IM,
  Prochaska JH, Arnold N, Binder H, Schmidtmann I, Beutel ME, Pfeiffer N, Münzel
  T, Lackner KJ, Ten Cate H, Wild PS, Spronk HMH. Thrombin generation in
  cardiovascular disease and mortality - results from the Gutenberg Health Study.
  Haematologica. 2020.
• Göbel S, Prochaska JH, Tröbs SO, Panova-Noeva M, Espinola-Klein C, Michal M,
  Lackner KJ, Gori T, Münzel T, Wild PS. Rationale, design and baseline
  characteristics of the MyoVasc study: A prospective cohort study investigating
  development and progression of heart failure. Eur J Prev Cardiol. 2020.
• Hahad O, Wild PS, Prochaska JH, Schulz A, Lackner KJ, Pfeiffer N,
  Schmidtmann I, Michal M, Beutel M, Daiber A, Münzel T. Midregional pro atrial
  natriuretic peptide: a novel important biomarker for noise annoyance-induced
  cardiovascular morbidity and mortality? Clin Res Cardiol. 2021.
• Prochaska JH, Müller F, Wild PS. Impact of diesel exposure on human health:
  the saga continues …. Eur J Prev Cardiol. 2020.
• Ten Cate V, Eggebrecht L, Schulz A, Panova-Noeva M, Lenz M, Koeck T, Rapp S,
  Arnold N, Lackner KJ, Konstantinides S, Espinola-Klein C, Münzel T, Prochaska
  JH, Wild PS. Isolated Pulmonary Embolism Is Associated With a High Risk of
  Arterial Thrombotic Disease: Results From the VTEval Study. Chest. 2020.
• Lauterbach M, Uhrich E, Eggebrecht L, Göbel S, Panova-Noeva M, Nagler M, Ten
  Cate V, Bickel C, Espinola-Klein C, Münzel T, Wild PS, Prochaska JH. Specialized
  Management of Oral Anticoagulation Therapy Improves Outcome in Patients with
  Chronic Renal Insufficiency. J Clin Med. 2020.
• Michal M, Eggebrecht L, Göbel S, Panova-Noeva M, Nagler M, Arnold N,
  Lauterbach M, Bickel C, Wiltink J, Beutel ME, Münzel T, Wild PS, Prochaska JH.
  The relevance of depressive symptoms for the outcome of patients receiving
  vitamin K-antagonists: Results from the thrombEVAL cohort study. Eur Heart J
  Cardiovasc Pharmacother. 2020.
• Panova-Noeva M, Wagner B, Nagler M, Arnold N, Prochaska JH, Eckerle S,
  Spronk HM, Merzenich H, Wingerter A, Schneider A, Danckwardt S, Ten Cate H,
  Faber J, Wild PS. Relation between platelet coagulant and vascular function,
  sex-specific analysis in adult survivors of childhood cancer compared to a
  population-based sample. Sci Rep. 2019.
• Hahad O, Prochaska JH, Daiber A, Muenzel T. Environmental Noise-Induced
  Effects on Stress Hormones, Oxidative Stress, and Vascular Dysfunction: Key
  Factors in the Relationship between Cerebrocardiovascular and Psychological
  Disorders. Oxid Med Cell Longev. 2019.
• Herzog J, Schmidt FP, Hahad O, Mahmoudpour SH, Mangold AK, Garcia Andreo P,
  Prochaska J, Koeck T, Wild PS, Sørensen M, Daiber A, Münzel T. Acute exposure to
  nocturnal train noise induces endothelial dysfunction and pro-
  thromboinflammatory changes of the plasma proteome in healthy subjects. Basic
  Res Cardiol. 2019.
• Hahad O, Wild PS, Prochaska JH, Schulz A, Hermanns I, Lackner KJ, Pfeiffer
  N, Schmidtmann I, Beutel M, Gori T, Deanfield JE, Münzel T. Endothelial Function
  Assessed by Digital Volume Plethysmography Predicts the Development and
  Progression of Type 2 Diabetes Mellitus. J Am Heart Assoc. 2019.
• Labenz C, Prochaska JH, Huber Y, Nagel M, Straub BK, Wild P, Galle PR,
  Schattenberg JM. Cardiovascular Risk Categories in Patients With Nonalcoholic
  Fatty Liver Disease and the Role of Low-Density Lipoprotein Cholesterol. Hepatol
  Commun. 2019.
• Prochaska JH, Hausner C, Nagler M, Göbel S, Eggebrecht L, Panova-Noeva M,
  Arnold N, Lauterbach M, Bickel C, Michal M, Hardt R, Espinola-Klein C, Lackner
  KJ, Münzel T, Wild PS. Subtherapeutic Anticoagulation Control under Treatment
  with Vitamin K-Antagonists-Data from a Specialized Coagulation Service. Thromb
  Haemost. 2019.
• Börschel CS, Rübsamen N, Ojeda FM, Wild PS, Hoffmann BA, Prochaska JH, Gori T, Lackner KJ, Blankenberg S, Zeller T, Münzel T, Schnabel RB. Noninvasive peripheral vascular function and atrial fibrillation in the general population. J Hypertens. 2019.
• Münzel T, Hahad O, Gori T, Hollmann S, Arnold N, Prochaska JH, Schulz A, Beutel M, Pfeiffer N, Schmidtmann I, Lackner KJ, Keaney JF Jr, Wild PS. Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study. Clin Res Cardiol. 2019.
• Ten Cate V, Nagler M, Panova-Noeva M, Eggebrecht L, Arnold N, Lamparter H, Hermanns MI, Ten Cate H, Prins MH, Espinola-Klein C, Münzel T, Lackner KJ, Wild PS, Prochaska JH. The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of venous thromboembolism. Haematologica 2019.
• Eggebrecht L, Prochaska JH, Tröbs SO, Schwuchow-Thonke S, Göbel S, Diestelmeier S, Schulz A, Arnold N, Panova-Noeva M, Koeck T, Rapp S, Gori T, Lackner KJ, Ten Cate H, Münzel T, Wild PS. Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism. Clin Res Cardiol 2019.
• Eggebrecht L, Nagler M, Göbel S, Lamparter H, Keller K, Wagner B, Panova-Noeva M, Ten Cate V, Bickel C, Lauterbach M, Espinola-Klein C, Hardt R, Münzel T, Prochaska JH, Wild PS. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists. J Am Geriatr Soc 2019;67(3):463-470.
• Burghardt J, Klein E, Brähler E, Ernst M, Schneider A, Eckerle S, Neu MA, Wingerter A, Henninger N, Panova‐Noeva M, Prochaska J, Wild P, Beutel M, Faber J. Prevalence of mental distress among adult survivors of childhood cancer in Germany—Compared to the general population. Cancer Medicine 2019;8(4):1865-1874.
• Börschel CS, Rübsamen N, Ojeda FM, Wild PS, Hoffmann BA, Prochaska JH, Gori T, Lackner KJ, Blankenberg S, Zeller T, Münzel T, Schnabel RB. Noninvasive peripheral vascular function and atrial fibrillation in the general population. J Hypertens 2019;37(5):928-934.
• Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S, Konstantinides SV, Barco S. Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 2018;172:74-79.
• Göbel S, Prochaska JH, Eggebrecht L, Schmitz R, Jünger C, Lamparter H, Nagler M, Keller K, Coldewey M, Tröbs SO, Diestelmeier S, Schwuchow-Thonke S, Bickel C, Lauterbach M, Lackner KJ, Cate HT, Münzel T, Hardt R, Wild PS. Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study. Thromb Haemost 2018;118(11):1930-1939.
• Eggebrecht L, Prochaska JH, Schulz A, Arnold N, Jünger C, Gobel S, Laubert-Reh D, Binder H, Beutel ME, Pfeiffer N, Blankenberg S, Lackner KJ, Spronk HM, Ten Cate H, Münzel T, Wild PS. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study. J Am Heart Assoc 2018;7(17):e008650.
• Prochaska JH, Luther N, Brähler M, Schulz A, Hermanns MI, Lackner KJ, Espinola-Klein C, Münzel T, Wild PS, Becker C. Acute deep vein thrombosis suppresses peripheral T cell effector function. Br J Haematol 2019;184(5):847-850.
• Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Münzel T, Lackner KJ, Beutel ME, Blettner M, Rathmann W, Peters A, Meisinger C, Linkohr B, Neuhauser H, Kaatsch P, Spix C, Schneider A, Merzenich H, Panova-Noeva M, Prochaska JH, Wild PS. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J 2018;39(17):1555-1562.
• Magnussen C, Ojeda FM, Wild PS, Sorensen N, Rostock T, Hoffmann BA, Prochaska J, Lackner KJ, Beutel ME, Blettner M, Pfeiffer N, Rzayeva N, Sinning CR, Blankenberg S, Münzel T, Zeller T, Schnabel RB. Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study). Am J Cardiol 2018;122(1):76-82.
• Panova-Noeva M, Schulz A, Arnold N, Hermanns MI, Prochaska JH, Laubert-Reh D, Spronk HM, Blettner M, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Ten Cate H, Wild PS. Coagulation and inflammation in long-term cancer survivors: results from the adult population. J Thromb Haemost 2018;16(4):699-708.
• Panova-Noeva M, Schulz A, Spronk HM, Beicht A, Laubert-Reh D, van Oerle R, Arnold N, Prochaska JH, Blettner M, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Ten Cate H, Wild PS. Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets-Results from the Gutenberg Health Study. Thromb Haemost 2018;118(5):873-882.
• Parry BA, Chang AM, Schellong SM, House SL, Fermann GJ, Deadmon EK, Giordano NJ, Chang Y, Cohen J, Robak N, Singer AJ, Mulrow M, Reibling ET, Francis S, Griffin SM, Prochaska JH, Davis B, McNelis P, Delgado J, Kumpers P, Werner N, Gentile NT, Zeserson E, Wild PS, Limkakeng AT, Jr., Walters EL, LoVecchio F, Theodoro D, Hollander JE, Kabrhel C. International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs. Thromb Res 2018;166:63-70.
• Prochaska JH, Göbel S, Nagler M, Knöpfler T, Eggebrecht L, Lamparter H, Panova-Noeva M, Keller K, Coldewey M, Bickel C, Lauterbach M, Hardt R, Espinola-Klein C, Ten Cate H, Rostock T, Münzel T, Wild PS. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure. Clin Res Cardiol 2018;107(12):1170-1179.
• Hahad O, Beutel M, Gori T, Schulz A, Blettner M, Pfeiffer N, Rostock T, Lackner K, Sørensen M, Prochaska JH, Wild PS, Münzel T. Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study. Int J Cardiol. 2018;264:79-84.
• Eggebrecht L*, Prochaska JH*, Schleuter L, Nagler M, Hardt R, Schinzel H, Münzel T, Wild PS. [Physicians' Opinion on Health Care in Oral Anticoagulation]. Dtsch Med Wochenschr 2017.
• Arnold N, Gori T, Schnabel RB, Schulz A, Prochaska JH, Zeller T, Binder H, Pfeiffer N, Beutel M, Espinola-Klein C, Lackner KJ, Blankenberg S, Münzel T, Wild PS (2017) Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis - Data from the Population-based Gutenberg Health Study. Scientific reports 7: 6346
• Prochaska JH, Frank B, Nagler M, Lamparter H, Weisser G, Schulz A, Eggebrecht L, Göbel S, Arnold N, Panova-Noeva M, Hermanns I, Pinto A, Konstantinides S, Ten Cate H, Lackner KJ, Münzel T, Espinola-Klein C, Wild PS (2017) Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis. Scientific reports 7: 4591
• Luque Ramos A, Ohlmeier C, Enders D, Linder R, Horenkamp-Sonntag D, Prochaska JH, Mikolajczyk R, Garbe E (2017) Initiation and duration of dual antiplatelet therapy after inpatient percutaneous coronary intervention with stent implantation in Germany: An electronic healthcare database cohort study. Z Evid Fortbild Qual Gesundhwes 120: 31-38
• Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Schulz A, Schinzel H, Bickel C, Lauterbach M, Michal M, Hardt R, Binder H, Espinola-Klein C, Lackner KJ, Ten Cate H, Münzel T, Wild PS (2017) e-Health based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study. Journal of thrombosis and haemostasis 
• Panova-Noeva M, Arnold N, Hermanns MI, Prochaska JH, Schulz A, Spronk HM, Binder H, Pfeiffer N, Beutel M, Blankenberg S, Zeller T, Lotz J, Münzel T, Lackner KJ, ten Cate H, Wild PS. Mean Platelet Volume and Arterial Stiffness – Clinical Relationship and Common Genetic Variability. Sci Rep 2017. Vol 7 pp. 40229.
• Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Jünger C, Al-Bayati Z, Baer C, Walter U, Bickel C, Ten Cate H, Münzel T, Wild PS. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service - results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015 Jan 23;13(1):14. 
• Michal M, Prochaska JH, Keller K, Göbel S, Coldewey M, Ullmann A, Schulz A, Lamparter H, Münzel T, Reiner I, Beutel ME, Wild PS. Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program. Int J Cardiol. 2015; 187:614-9.
• Zolfaghari S, Harenberg J, Frölich J, Weiss C, Wehling M, Wild P, Prochaska J, Beyer-Westendorf J, Koscielny J, Lip GY. Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients´ preference. Semin Thromb Hemost. 2015 Mar;41(2):166-77.
• Keller K, Prochaska JH, Coldewey M, Gobel S, Ullmann A, Jünger C, Lamparter H, Ariza L, Bickel C, Lauterbach M, Konstantinides S, Rostock T, Münzel T, Wild PS. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism. Thromb Res. 2015 Nov; 136(5):899-906.
• Prochaska JH, Gobel S, Hendelmeier M, Coldewey M, Keller K, Konstantinides S, Münzel T, Wild PS. Evaluation of oral anticoagulation therapy with vitamin K antagonists: Rationale and design of the thrombEVAL study programme. Eur J Prev Cardiol. 2015 May;22(5):622-8.
• Frank B, Ariza L, Lamparter H, Grossmann V, Prochaska JH, Ullmann A, Kindler F, Weisser G, Walter U, Lackner KJ, Espinola-Klein C, Münzel T, Konstantinides SV, Wild PS. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thrombobembolism: the VTEval Project. BMJ Open. 2015 Jul 1; 5(7):e008157.
• Schnabel RB, Wild PS, Prochaska JH, Ojeda FM, Zeller T, Rzayeva N, Ebrahim A, Lackner KJ, Beutel ME, Pfeiffer N, Sinning CR, Oertelt-Prigione S, Regitz-Zagrosek V, Binder H, Münzel T, Blankenberg S. Sex differences in correlates of intermediate phenotypes and prevalent cardiovascular disease in the general population. Front Cardiovasc Med. 2015 Apr 15;2:15.
• Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler B, Romero I, Couraud PO, Stoll G, Rieckmann P, Buttmann M. Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One. 2010 Oct 21;5(10):e13568.

Editorial

• Prochaska JH, Wild PS. Traffic-associated air pollution as a risk factor for cancer in individuals with coronary artery disease. Eur J Prev Cardiol 2018:2047487318768942.